March 18, 2025 04:15 AM EDTUpdated 06:15 AM
Financing
Startups

Sofinno­va Part­ners lands €165M, backed by big phar­ma, to build ear­ly-stage biotechs in Eu­rope

Kyle LaHucik

Senior Reporter

Eu­ro­pean life sci­ences in­vestor Sofinno­va Part­ners dis­closed a €165 mil­lion ac­cel­er­a­tion fund on Tues­day to back ear­ly-stage sci­ence in Italy, France, the Unit­ed King­dom and …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Six­teen-year-old dies af­ter re­ceiv­ing Sarep­ta’s Duchenne gene ther­a­py

CRISPR com­pa­ny Ar­bor rais­es $73.9M to test ther­a­py in clin­i­cal tri­als

As­traZeneca taps Al­teogen in deal worth more than $1.3B to make sub­cu­ta­neous can­cer drugs

As­traZeneca re­ports Phase 3 suc­cess for rare dis­ease drug at heart of Amolyt deal

Trump’s HHS de­fends Biden-era stance on 340B re­bate mod­els

FDA staff re­turn to White Oak cam­pus en masse af­ter Trump ad­min­is­tra­tion push

A service from the Financial Times